Hyderabad based generic pharmaceutical company Hetero Labs is working
on a "war footing" to make remdesivir available for Covid-19 patients
in India, having entered into a licensing agreement with US-based
Gilead Sciences to manufacture and market the antiviral drug in 127
countries, Hetero Labs' managing director Vamsi Krishna Bandi told
ET's Teena Thacker in an interview.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/we-will-ensure-remdesivir-supply-when-india-wants-it/articleshow/75728653.cms
No comments:
Post a Comment